Increased serum levels of mutant p53 proteins in patients with colorectal cancer.

Increased serum levels of mutant p53 proteins in patients with colorectal cancer.

We have examined the serum levels of the mutant p53 protein in patients with colorectal cancer preoperatively (n=50), and in patients with adenomatous polyp (n=13). Mutant p53 protein in patients after curative surgical resection of colorectal cancer (n=26, part of the fifty preoperative patients) w...

Full description

Bibliographic Details
Main Authors:	Shim, K. S., Kim, K. H., Park, B. W., Lee, S. Y., Choi, J. H., Han, W. S., Park, E. B.
Format:	Online
Language:	English
Published:	Korean Academy of Medical Sciences 1998
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054335/

Similar Items

Increased serum p53 antibody levels indicate poor prognosis in patients with colorectal cancer.
by: Kressner, U., et al.
Published: (1998)

Increased p53 protein content of colorectal tumours correlates with poor survival.
by: Remvikos, Y., et al.
Published: (1992)

The Increased Level of Serum p53 in Hepatitis B-Associated Liver Cirrhosis
by: Shahnazari, Parisa, et al.
Published: (2014)

An immunohistochemical study of the expression of p53 protein in colon cancer.
by: Kim, Y. W., et al.
Published: (1995)

A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis
by: Yue, Xuetian, et al.
Published: (2016)

Expression of p53 protein, PCNA, and Ki-67 in osteosarcomas of bone.
by: Park, H. R., et al.
Published: (1995)

Big bones in p53 mutants
by: LeBrasseur, Nicole
Published: (2006)

Mutant p53 succumbs to starvation
by: Moon, Sung-Hwan, et al.
Published: (2013)

Chromatin dysregulation by mutant p53
by: Pfister, Neil T., et al.
Published: (2016)

p53 protein overexpression and allele loss of p53 gene in gastric adenocarcinoma.
by: Choi, S. W., et al.
Published: (1994)

Regulation of Mutant p53 Protein Expression
by: Vijayakumaran, Reshma, et al.
Published: (2015)

Mutant p53 accumulates in cycling and proliferating cells in the normal tissues of p53 R172H mutant mice
by: Goh, Amanda M., et al.
Published: (2015)

P-glycoprotein is not expressed in a majority of colorectal carcinomas and is not regulated by mutant p53 in vivo.
by: De Angelis, P., et al.
Published: (1995)

Topographic expression of p21WAF1/SDI1/CIP1, bcl2, and p53 is altered at the early stage of colorectal carcinogenesis.
by: Cho, J. H., et al.
Published: (2000)

p53 is active in murine stem cells and alters the transcriptome in a manner that is reminiscent of mutant p53
by: Yan, H, et al.
Published: (2015)

Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53
by: Vikhanskaya, Faina, et al.
Published: (2007)

Role of p53 gene mutation in tumor aggressiveness of intracranial meningiomas.
by: Cho, H., et al.
Published: (1999)

Δ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant
by: Slatter, T L, et al.
Published: (2015)

Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas.
by: Dix, B., et al.
Published: (1994)

Targeting Oncogenic Mutant p53 for Cancer Therapy
by: Parrales, Alejandro, et al.
Published: (2015)

Mutant p53 and sIL-1Ra
by: Bossi, Gianluca
Published: (2015)

Targeting mutant p53 for cancer therapy
by: Oren, Moshe, et al.
Published: (2016)

Quaternary structure of the specific p53–DNA complex reveals the mechanism of p53 mutant dominance
by: Aramayo, Ricardo, et al.
Published: (2011)

Increased expression and mutation of p53 in choroidal melanoma.
by: Tobal, K., et al.
Published: (1992)

Functional interplay between MDM2, p63/p73 and mutant p53
by: Stindt, M H, et al.
Published: (2015)

Gain of function of mutant p53: R282W on the peak?
by: Zhang, Y, et al.
Published: (2016)

Periostin cooperates with mutant p53 to mediate invasion through the induction of STAT1 signaling in the esophageal tumor microenvironment
by: Wong, G S, et al.
Published: (2013)

p53 and Rb1 protein expression: are they prognostically useful in colorectal cancer?
by: Poller, D. N., et al.
Published: (1997)

Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
by: Muller, Patricia A.J., et al.
Published: (2014)

Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas.
by: Smith, D. R., et al.
Published: (1996)

p53 and its mutants in tumor cell migration and invasion
by: Muller, Patricia A. J., et al.
Published: (2011)

Mutant p53 protein expression and antioxidant status deficiency in breast cancer
by: Milicevic, Zorka, et al.
Published: (2014)

Utility of the p53 mutant protein in patients with low-risk myelodysplastic syndrome
by: Yao, David C., et al.
Published: (2014)

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer
by: Hofstetter, G, et al.
Published: (2011)

Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer.
by: Kaklamanis, L., et al.
Published: (1998)

Mutation of the p53 gene precedes aneuploid clonal divergence in colorectal carcinoma.
by: Carder, P. J., et al.
Published: (1995)

The Hsp90 inhibitor 17-(allylamino)-17-demethoxygeldanamycin increases cisplatin antitumor activity by inducing p53-mediated apoptosis in head and neck cancer
by: Roh, J-L, et al.
Published: (2013)

p53 Mutations and DNA Ploidy in Colorectal Adenocarcinomas
by: Campomenosi, Paola, et al.
Published: (1998)

Effects of p53 mutants derived from lung carcinomas on the p53-responsive element (p53RE) of the MDM2 gene.
by: Gorgoulis, V. G., et al.
Published: (1998)

Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer.
by: Kopreski, M. S., et al.
Published: (1997)